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Abstract
Introduction: The synovium is a major target tissue in chronic arthritis and is intensively studied at the cellular and
molecular level. The aim of this study was to develop flow cytometry for the quantitative analysis of synovial cell
populations pre and post culture and to characterize mesenchymal cell populations residing in the inflammatory
synovium.
Methods: Knee synovium biopsies from 39 patients with chronic arthritis and from 15 controls were treated in a
short, standardized tissue digestion procedure. Stored, thawed digests were routinely analyzed with flow cytometry
including live-dead staining and use of the markers CD45, CD3, CD14, CD20, CD34, CD73, CD105, CD90, CD146,
CD163 and HLA-DR to distinguish inflammatory and stromal cells. The influence of the digestion method on the
detection of the different surface markers was studied separately. In addition, we studied the presence of a specific
cell population hypothesized to be mesenchymal stem cells (MSC) based on the CD271 marker. Cell expansion
cultures were set up and a MSC-related surface marker profile in passages 3 and 6 was obtained.
Immunohistochemistry for CD34 and von Willebrand factor (vWF) was done to obtain additional data on synovium
vascularity.
Results: The cell yield and viability normalized to tissue weight were significantly higher in inflammatory arthritis
than in controls. Within the hematopoietic CD45-positive populations, we found no differences in relative amounts
of macrophages, T-lymphocytes and B-lymphocytes between patient groups. Within the CD45-negative cells, more
CD34-positive cells were seen in controls than in arthritis patients. In arthritis samples, a small CD271 positive
population was detected. Culture expanded cells were found to fulfill the multipotent mesenchymal stromal cell
marker profile, except for CD34 negativity. Detection of peripheral blood macrophage and B-cell markers was
decreased after enzymatic exposure and mechanical forces, respectively, but stromal markers were not affected.
Conclusions: Flow cytometry can distinguish synovial cell populations in tissue digests. The preparation method
can influence the detection levels of macrophage and B-cell populations. However, stromal cell markers seem not
affected and quantification is possible, supporting flow cytometry tissue analysis as a tool to study these cell
populations in arthritis.
Introduction
Inflammation, loss of synovial homeostasis and progres-
sive synovial-mediated joint destruction are critical fea-
tures of inflammatory arthritis. Not surprisingly, the
synovium has been a preferred tissue for the investiga-
tion of cellular and molecular mechanisms in arthritic
diseases such as rheumatoid arthritis (RA) and spondy-
loarthritis (SpA). Historically, synovial tissue analysis
was carried out in tissue obtained during joint replace-
ment surgery but advances in needle arthroscopy with
increased access to small synovial biopsies has facilitated
the study of synovitis at the cellular and molecular
levels. Currently, synovial tissue analysis is used in clini-
cal trials, in translational science studies and even in
routine clinical practice [1].
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method of analysis for the detection and quantification
of synovial cell populations [2]. With this method, both
semi-quantitative and quantitative digital image analyses
have been proposed as tools to compare samples [1,2].
However, immunohistochemistry has a number of draw-
backs. By its two-dimensional character, reconstruction
of the total biopsy content is a laborious task, while
each tissue slice analyzed provides information about a
rather limited cell number. The interfacing steps
between visible signals and quantitative digital data are
not fully automated and therefore quite labour intensive
and specialized. Performing double staining is possible,
but multicolor staining is very difficult to achieve.
Further, the technique is certainly not devoid of variabil-
ity between centers with variations in tissue preserva-
tion, fixation, and staining. Even if under perfect
circumstances specific molecular signals can be detected
and localized reliably, this information represents the
endpoint of investigation because the cells cannot be
studied further with respect to their function.
Another method for studying synovial cells is the in
vitro expansion of synovium-derived, plastic-adherent
cell populations, mostly fibroblast-like cells. Molecular
and functional characteristics obtained with these cells
can be counted as circumstantial evidence for mechan-
isms involved in disease pathogenesis [3-5]. However,
this approach will probably not deliver the key informa-
tion about the mechanisms by which these stromal cells
modulate tissue responses in vivo. Selection of plastic
adherent cells is typically used to study cell phenotype
and function, but this further stresses the question to
what extent manipulations influence cell behavior in
comparison with the original in vivo situation. Multiple
variables are inherent to the technique: polyclonal versus
clonal culture, use of bovine products or not, and pas-
sage kinetics can all influence the cell phenotype which
is finally studied.
Flow cytometry is a robust and well-established tech-
nique that has found wide application in cellular charac-
terization and could overcome many of the limitations
associated with immunohistochemistry and tissue cul-
ture. However, it has thus far surprisingly little applica-
tion in joint-derived tissue in the study of arthritis. Flow
cytometry is known as an excellent phenotyping tool,
because multiple molecules, surface markers as well as
intracellular proteins, can be detected in individual cells
[6]. Also, it is appreciated for its rapid, automated quan-
tification leading to the evaluation of rare cells. Finally,
sorting of the cells allows their further use in functional
in vitro or in vivo assays. Hence, flow cytometry is an
attractive application for synovial tissue analysis.
Flow cytometry has been previously used to study
non-cultured synovial cell suspensions, focusing either
on lymphocyte and macrophage cell populations [7-9]
or on the characterization of mesenchymal cells [10] or
both [11]. We wanted to use known basic markers for
stromal cells [12] as well as additional promising mar-
kers such as CD146 (melanoma cell adhesion molecule
[13] and CD271 (low-affinity nerve growth factor recep-
tor) [14-17] that were recently associated with specific
multipotent mesenchymal cell populations, as a first
step to explore different populations of synovium-
derived cells. We analyzed the cellular composition of
fresh synovial tissue digests with flow cytometry to
develop a standard operating procedure. Given that
solid tissue enzymatic disaggregation is known to cleave
certain membrane markers we also evaluated how this
affected the results obtained. Herein, we propose a
robust protocol that permits the study of fresh human
synovial cell populations with widespread application in
translational research and we demonstrate that this
method is useful to distinguish specific stromal cells.
Materials and methods
Patient and control materials
Fifteen control patients suffering from knee pain and
planning to undergo orthopedic knee arthroscopy, were
recruited into the study. Diagnostic data were recorded
during the arthroscopy. A total of 39 arthritis patients,
suffering from inflammatory knee synovitis and referred
for needle arthroscopy by their rheumatologist, were
included in this study. Twelve arthritis patients fulfilled
the revised American College of Rheumatology criteria
for RA [18]. In 24 patients a diagnosis of SpA was made
with the patients fulfilling the European Spondyloarthro-
pathy Study Group criteria [19] or in case of psoriatic
arthritis, the ClASsification of Psoriatic ARthritis study
group criteria [20]. In three patients with chronic syno-
vitis (more than six weeks’ duration), no definitive diag-
nosis could be made. In orthopedic patients but not in
arthritis patients, the blood flow was controlled during
the arthroscopy procedure by the application of a tour-
niquet above the knee joint. Peripheral blood was
obtained from healthy volunteers. Human cord blood
(not fulfilling clinical cryopreservation criteria) was a
gift from the Hematology Department. The procedures
were approved by the Local Ethics Committee (Univer-
sity Hospitals K.U. Leuven) and written informed con-
sent was obtained from each patient.
Isolation and cryopreservation of synovial cells
In control patients, three large biopsies (median total
weight 342 mg, quartiles 258 to 370 mg) were collected
during orthopedic knee art h r o s c o p yb yt h es u r g e o n
while in arthritic patients, four smaller biopsies (median
total weight 45 mg, quartiles 24 to 83 mg) were
obtained blindly during a single port needle arthroscopy.
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(DPBS; Lonza, Verviers, Belgium) and finely minced
with a scalpel and a needle. A two-step procedure was
used for the digestion. First, hyaluronidase from bovine
testes (SigmaAldrich, Bornem, Belgium), was dissolved
in DMEM supplemented with 1% antibiotics/antimyco-
t i c s+1 %s o d i u mp y r u v a t e( S P )( a l lf r o mI n v i t r o g e n ,
Merelbeke, Belgium) + 0.1% albumin bovine fraction V
(Serva, Heidelberg, Germany), to obtain a hyaluronidase
solution of 1000 units/ml (approximately 0.1%), and fil-
tered with a 0.22 μm filter (Millipore, Brussels, Bel-
gium). For orthopedic samples, a double amount (4000
units/sample) of active enzyme compared with arthritis
samples (2000 units/sample) was used due to the larger
size of the biopsies. The minced tissue was dropped in
the solution, weighed, and subsequently incubated for
15 minutes at 37°C with continuous rotation at 16 to 20
revolutions/minute (rpm). A second enzyme solution
c o n s i s t e do f1 0 0 0u n i t s / s a m ple (arthritis samples) or
2000 units/sample (orthopedic samples) of collagenase
type IV from Clostridium histolyticum (Invitrogen, Mer-
elbeke, Belgium). This solution was added to the tubes
containing the first solution and the tissue, the final
concentration of collagenase being 400 units/ml
(approximately 0.2%). After two hours of further diges-
tion with rotation, cells were centrifuged, washed and
sieved through a nylon 70 μmc e l ls t r a i n e r( B DB i o s -
ciences, Erembodegem, Belgium). Cells were centrifuged
and resuspended in growth medium being DMEM sup-
plemented with 1% antibiotics/antimycotics, 1% SP and
10% fetal bovine serum (FBS) (Bio Whittaker, Verviers,
Belgium). Cells were counted in a Bürker chamber after
staining with trypan blue (Sigma-Aldrich, Bornem, Bel-
gium). The suspension was either immediately seeded in
cell culture (see below) or was gradually mixed at 1:1
with freezing medium being DMEM supplemented with
20% FBS and 20% dimethylsulfoxide (DMSO; Sigma-
Aldrich, Bornem, Belgium). In three arthritis patients,
20% of the digest was seeded in cell culture while the
rest was frozen in order to compare the digest with the
cultured cells from the same patient. Cells were frozen
gradually (in an isopropanol freezing container) to -80°C
overnight and transferred afterwards to liquid nitrogen.
Staining of frozen digests
For flow cytometry staining, antibodies conjugated with
fluoro-isothiocyanate (FITC), phycoerythrin (PE) or allo-
phycocyanin (APC) were used. CD45-FITC (clone
HI30), CD19-PE (clone HIB19), CD73-PE (clone
AD2), CD90-PE (clone 5E10), CD146-PE (clone P1H12),
CD163-PE (clone GHI/61), CD271-PE (clone C40/1457),
human leucocyte antigen (HLA) DR-PE (clone
G46-6), CD3-APC (clone UCHT1), CD34-APC (clone
581), and isotype controls immunoglobulin (Ig)G1-FITC,
IgG1-PE, IgG1-APC were purchased from BD Bios-
ciences (Erembodegem, Belgium). CD20-PE (clone
LT20), CD14-APC (clone TUK4) and IgG2a-APC were
purchased from Miltenyi-Biotech (Utrecht, the Nether-
lands). CD105-APC (endoglin, clone 166707) was from
R&D systems (Minneapolis, MN, USA). 7-amino-actino-
mycin (7-AAD) (Calbiochem, San Diego, CA, USA) was
reconstituted with PBS/DMSO 4:1 to a concentration of
200 μg/ml. For washes, incubation and acquisition of
the data, cells were suspended in incubation buffer
(DPBS + 2% FBS + 1 mM ethylenediaminetetraacetic
acid (EDTA)). Data were acquired on a FACSCanto cyt-
ometer (BD Biosciences, Erembodegem, Belgium) and
analysis of the data was performed using BD FACSDiva
5.0 software (BD Biosciences, Erembodegem, Belgium).
The synovial cells were thawed quickly, suspended in 5
ml of DMEM/10% FBS and centrifuged. Cells were
resuspended in incubation buffer. For each sample,
there were five different staining tubes with a minimum
of 10,000 and a maximum of 500,000 cells per tube. For
each patient, three or four different triple stainings were
performed, constantly including CD45 combined with
two other markers. This doublet could be CD20 with
CD3, CD14 with CD163, or CD34 with CD73, CD90,
CD146, CD271 or HLA-DR. For each patient, isotype
control stainings were matched to these combinations.
Per tube, 5 to 20 μl of antibody was applied directly on
the pellet (depending on the cell number and the manu-
facturers’ recommendations, with a minimum of 5 μl
per tube), followed by an incubation of 45 minutes at 4°
C in the dark. Cells were washed with incubation buffer,
spun down and resuspended in 250 μlo fi n c u b a t i o n
buffer. 7-AAD solution was added (to a final concentra-
tion of 2.5 μg/ml), followed by incubation during 10
minutes on ice.
Cell culture
For five control samples and five samples from RA
patients, all isolated cells were seeded in a plastic cul-
ture dish (Greiner, Wemmel, Belgium). In addition, for
three samples from undifferentiated arthritis and SpA,
part of the obtained cells were seeded in order to com-
pare the digest with the cultured cells for each patient.
Cells were seeded on a fixed surface area, 10 cm
2 for
arthritis samples and 75 cm
2 for control samples. Cells
were allowed to attach during four to five days before
replacing the growth medium being DMEM supplemen-
ted with 1% antibiotics/antimycotics, 1% SP, and 10%
FBS. After 10 to 14 days, when cells were confluent,
they were rinsed with DPBS, enzymatically harvested
with TrypLE express (Invitrogen, Merelbeke, Belgium),
washed, counted, and replated at a density of approxi-
mately 5000 cells/cm
2. Further passages were performed
upon confluence. Cells were expanded up to passage six
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two (culture period around four weeks) for three addi-
tional arthritis patients.
Flow cytometry staining of cultured cells
The choice of the antibodies used was based on the
minimal surface marker panel proposed by the Interna-
tional Society of Cellular Therapy [12]. CD45-FITC,
CD34-FITC (clone 581), CD14-PE (clone MFP9),
CD73-PE, CD79a-PE (clone HM47), CD90-PE, HLA-
DR-PE, IgG1-FITC, IgG1-PE, IgG2a-PE were from BD
Biosciences (Erembodegem, Belgium). CD20-PE was
from Miltenyi (Utrecht, the Netherlands) and CD105-
FITC (clone 166707) was from R&D systems (Minnea-
polis, MN, USA). Upon confluence, cells from one 75
cm
2 flask were harvested, washed and counted. They
were kept on ice and suspended in incubation buffer
(DPBS + 2% FBS + 1 mM EDTA). After centrifugation
and aspiration of supernatant, 5 or 10 μl (depending on
the cell number per tube) of the antibodies were applied
directly onto the pellet. Only one antibody was used per
tube to minimize signal compensation problems with
the strong autofluorescence signal emerging from cells
in higher passage numbers. Cells were incubated at 4°C
for 30 to 45 minutes. Cells were washed, resuspended,
and data were acquired and analyzed. For three other
patient samples, cultured cells (P1 or P2) were only
stained with CD271-PE and with CD34-APC and their
controls, here also including a double staining.
Measurement of enzymatic and mechanical effects
Peripheral blood mononuclear cells (PBMCs) were iso-
l a t e df r o mv e n o u sb l o o db yd e nsity centrifugation with
Lymphoprep (Axis Shield, Oslo, Norway). One part of
the cells was immediately used for flow cytometry, other
parts were subjected to the mechanical and enzymatic
compounds of the synovial digestion procedure. For
enzymatic exposure, 6 to 48 × 10
6 PBMCs were treated
with 4000 units hyaluronidase and 2000 units collage-
nase in the same concentrations as used for the diges-
tion of synovium. For mechanical exposure, PBMCs
were subjected to rotation at different velocities (8 to 20
rpm). Cells were centrifuged, and subsequently counted
and used for flow cytometry analysis. In two experi-
ments, a part of the exposed cells were allowed to
recover for two hours at room temperature before
staining.
For CD34 expression, cord blood mononuclear cells
(CB-MNCs) were freshly isolated by density centrifuga-
tion. Partial enrichment for CD34-positive fraction was
performed with an EasySep CD34 selection kit using the
clone QBend10 (Stem Cell Technologies, Grenoble,
France). Subsequently, cells were divided into two condi-
tions: one part was immediately stained for CD34-APC
(clone 581), the other part was exposed to the combined
enzymatic and mechanical (8 rpm) treatment.
For control on expression of CD73, CD90, and
CD105, human synovium-derived cells from RA patients
were cultured in plastic culture flasks for three or five
passages. The cells were harvested, washed and counted.
Part of the cells was exposed to the combined enzymatic
and mechanical (8 rpm) treatment, the other part was
directly stained. A similar protocol was used to test
for the expression of CD146, but here, fibroblasts were
not used but human osteosarcoma cells (gift from
Dr. J. Klein-Nulend from the Free University of Amster-
dam). CD146 is known as an endothelial marker in
healthy tissues, but it is also a multifaceted molecule
that can act as a promoter or suppressor of cancer [21].
Cells were stained with the tested antibodies and in
conditions similar to staining of the fresh digests, but on
cultured cells, no double or triple stainings were used
due to autofluorescence of these cells. For PBMCs and
CB-MNCs, approximately 700,000 cells were used per
tube in the stainings.
Immunohistochemistry of the synovial tissue
Six synovial biopsies per patient were fixed in 4% for-
maldehyde overnight, and transferred to methanol the
next day. After embedding in paraffin, serial sections (5
μm) were prepared on silanated slides. Quenching was
performed twice with 3% H2O2 for 10 minutes. Sections
were washed twice in PBS with 0.1% TritonX. After a
blocking step of 30 minutes with 1:5 diluted donkey
serum (Chemicon, Temecula, CA, USA), sections were
incubated overnight at 4°C with the following monoclo-
nal antibodies diluted in PBS/Triton: von Willebrand
Factor (vWF) (mouse anti-human IgG1 clone F8/86
purchased from Dako, Heverlee, Belgium) at 5 μg/ml
and CD34 (mouse anti-human IgG1 clone 581 pur-
chased from BD Biosciences (Erembodegem, Belgium) at
10 μg/ml. For controls, a mouse isotype antibody (Che-
micon, Temecula, CA, USA) was used at the same con-
centration. For the detection of vWF, a horseradish
peroxidase (HRP)-conjugated goat anti-mouse IgG (Jack-
son, Suffolk, UK) was used at 4 μg/ml and incubated
during 30 minutes. After washing steps, this was
detected by an enzymatic reaction with 3,3’-diaminoben-
zidine in chromogen solution (Dako, Heverlee, Belgium).
For the detection of CD34, a donkey anti-mouse biotin-
conjugated IgG-B (Santa Cruz, Heidelberg, Germany)
w a su s e da t2a n d4μg/ml (on consecutive sections),
followed by washing steps and incubation with an Avi-
din and Biotinylated HRP Macromolecular Complex
(Vector laboratories, Burlingame CA, USA) before final
color reaction with 3,3’-diaminobenzidine. Evaluation of
the staining was performed with a numerical qualitative
score. Score 1 was given to sections with the lowest
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to the highest amount of positive cells.
Statistical analysis
The Mann-Whitney U Test was used to detect differ-
ences between groups. Statistical significance was
defined as P < 0.05. The Spearman Rank Correlation
Test was used to detect correlation.
Results
Patient and tissue characteristics
Control patients (seven males/eight females) had a med-
ian age of 44 years. The reason for orthopedic arthro-
scopy was knee pain due to cartilage lesions (five
patients), meniscal lesions (three patients), combined
cartilage-meniscal injury (five patients), cruciate liga-
ment repair (one patient), and removal of a non-
resorbed intra-articular screw (one patient). Characteris-
tics of the patients from the arthritis group with estab-
lished diagnosis are shown in Table 1. The median cell
yield after digestion was 2286 cells/mg in the control
group vs. 20,222 cells/mg in the arthritis group (P <
0.001; Figure 1). The viability of the cells by trypan blue
exclusion was statistically different between both groups
(median 52% vs. 72%; P < 0.001). There was no correla-
tion between cell yield and viability for both groups.
Flow cytometry of frozen digests
Detection of the synovium-derived cells on the flow cyt-
ometer is based on two critical elements. Firstly, viability
staining excludes dead or apoptotic cells and debris
defining a gate based on forward scatter and on staining
for propidium iodide (PI) [11] or 7-AAD (Figure 2a).
Secondly, staining for CD45 separates cells of non-
hematopoietic origin from hematopoietic cells in the
FL1 channel [11] (Figure 2b). Other cell markers were
analyzed in the FL-3 (PE) and FL-4 (APC) channel.
Within non-hematopoietic cells, a majority of cells was
CD90-positive. This population comprises fibroblasts
and endothelial cells [22]. CD34 was positive in a subset
of CD90-positive cells and nearly all CD34-positive cells
also stained for CD90, albeit not brightly (Figure 2c).
Within hematopoietic cells, populations representing
T-lymphocytes (CD3+), B-lymphocytes (CD20+) and
monocytes (CD14+) could be recognized (Figure 2d).
The staining for CD163, a marker for alternatively acti-
vated macrophages in the synovium [23] was not suffi-
ciently discriminative for quantification. Within the
stromal compartment (CD45-negative cells), large popu-
lations expressing CD73 (median 81.3%, n = 8) and
CD105 (median 86%, n = 3) and smaller populations
expressing HLA-DR (median 36.5%, n = 6) and CD146
(median 5.6%, n = 8), also in part CD34-positive, were
seen (Figure 2e).
Before quantifying the different populations, we tested
whether tissue digestion might influence the detection
of immune cell markers, by exposing PBMCs to the pro-
cedure or its components and subsequently staining for
CD3, CD14, CD163, and CD20 (see Table 2 for experi-
ment set-up). B-cell and to a lesser extent macrophage
markers appeared to be sensitive to the procedure. In
specific experiments, the expression of CD19 and CD20
disappeared almost completely after rotation at 16 to 20
rpm, while slower rotation (8 rpm) could partially pre-
vent this effect (Figure 3a). Expression of CD14 and
CD163 was decreased by enzyme exposure but not
further decreased by rotation (Figure 3b). Markers of
each cell type decreased in a parallel way, suggesting
cell death to be the cause. On the forward scatter
(FSC)/side scatter (SSC) plots, we confirmed the disap-
pearance of macrophages/monocytes. Also, the relative
proportion of CD3-expression was increased, suggesting
decrease of the other populations. We also tested
whether expression of stromal markers was affected by
exposure to the complete digestion procedure in
cultured cells. Expression of CD34 in CD34-enriched
Table 1 Characteristics of arthritis patients
Rheumatoid arthritis (n = 12) Spondyloarthritis (n = 24)
Age (years) 43 (37.8-51.2) 37.5 (31-47.2)
Male/female 5/7 9/15
Disease duration (months) 33 (4.25-114) 7.5 (3.75-24)
CRP (mg/l) 39.7 (7.4-69.2) 10.5 (2.9-32.2)
ESR (mm/h) 41 (21-60.7) 25 (16.5-51)
WBC SF (cells/μl) 12,100 (9450-15500) 6900 (3050-10100)
DMARDs in use (by number of patients) no (7), hydroxychloroquine and sulphasalazine (1),
methotrexate (1), leflunomide (1), anti-TNF (2)
no (18), sulphasalazine (2),
methotrexate (3), leflunomide (1)
RF (% positive patients) 55 11
Anti-CCP (% positive patients) 70 19
Numbers indicate median with first and third quartiles unless otherwise indicated.
Anti-CCP = anti-cyclic citrullinated protein antibodies; CRP = C-reactive protein; DMARDs = disease-modifying anti-rheumatic drugs; ESR = erythrocyte
sedimentation rate; RF = rheumatoid factor; WBC SF = white blood cell count in synovial fluid.
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Page 5 of 14Figure 2 Analysis of total synovium-derived cell population with four-color flow cytometry: representative sample. Cells are stained
with 7-aminoactinomycin (7-AAD), CD45- fluoro-isothiocyanate (FITC), one phycoerythrin (PE)-conjugated antibody and one allophycocyanin
(APC)-conjugated antibody or their isotypes. (a) Dye exclusion of debris and dead cells in forward scatter (FSC)/FL3 in contour plot (top) and dot
plot (bottom). G1 gates for live cells. (b) Subgating of CD45-negative stromal (G2) and CD45-positive (G3) hematopoietic cell populations based
on isotype staining with IgG1-FITC and cell granularity (side scatter). (c) Quantification of CD34-expression and CD90-expression within the
stromal fraction. The gating for CD90-positive cells was based on IgG1-PE specifically measured on CD45-negative cells. (d) Quantification of
CD14, CD3, and CD20-expression within G3. The gating for CD20-positive cells was performed on IgG1-PE measured on total cells. (e) Plots
showing CD105-APC, CD73-PE, CD146-PE, and human leucocyte antigen (HLA)-DR-PE staining in the stromal fraction with their appropriate
isotype controls.
Figure 1 Microscopic evaluation of synovial cell yield and viability directly after isolation. Viability was counted as cells positive for trypan
blue.
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HLA-DR was affected to the same extent as the dying of
monocytes in total PBMCs (Figure 4b). Expression of
CD73 and CD105 (Figure 4c) and CD90 (data not
shown, off-scale fluorescence) in cultured synovium-
derived cells was not affected by the procedure, as was
the expression of CD146 in human osteosarcoma cells
(Figure 4d).
Quantification and detecting differences between patient
groups
As expected, biopsies from patients with inflammatory
arthritis contained a significantly larger proportion of
hematopoietic cells than the orthopedic controls
Figure 3 Influence of the isolation procedure on the detection of B-cell and macrophage markers: representative experiments.
Peripheral blood mononuclear cells (PBMCs) from healthy volunteers stained with 7-aminoactinomycin (7-AAD), CD45- fluoro-isothiocyanate
(FITC) and (a, top panel) CD20- phycoerythrin (PE) or (a, lower panel) CD19-PE, (b, top panel) CD14- allophycocyanin (APC) or (b, lower
panel) CD163-PE. Shown events were gated 7-AAD-negative and CD45-positive. Positivity for cell markers is shown in percentage of gated
events. (a) Influence on B-cell markers. Slow rotation: 8 rpm. Fast rotation: 16 to 20 rpm. (b) Influence on monocyte/macrophage markers.
Table 2 Influence of the digestion method on
composition of peripheral blood mononuclear cells
Collagenase
units/10
6 cells
Condition CD3
%
CD14
%
CD163
%
CD20
%
Donor 1 40 fresh 73.3 5.4 5.3 7.2
exposed 82.8 3.4 0.3 0.9
Donor 2 80 fresh 77.2 7.4 7.4 6.4
exposed 86.2 4.6 1.2 0.6
Donor 3 340 fresh 53 16.4 19.4 4.8
exposed 62.3 12 6.8 0.7
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a smaller proportion of non-hematopoietic cells than
the controls (median CD45-negative cells 16.9% vs. 67%,
P < 0.0001; Figure 5). Other results from the quantifica-
tion are depicted in Table 3. No differences were
detected concerning the CD45-positive subpopulations.
Within CD45-negative cells, the CD90-positive popula-
tion was not different between RA and SpA samples.
The CD34-positive population contains endothelial cells
[24]. CD34-expression was higher in the control samples
than in arthritis samples (P = 0.034). CD34-expression
was also higher in SpA than in RA, however, not statis-
tically significant (P = 0.089). By immunohistochemistry
for CD34 and vWF, median scores for CD34 were two
in the SpA group and one in the RA group (P =0 . 0 5 3 ) .
CD34 was positive in (sub)endothelium and also in cer-
tain stromal elements (Figure 6). There were no signifi-
cant correlations between stromal/hematopoietic cell
composition of the synovial digests and the inflamma-
tory status of the patient as assessed by C-reactive pro-
tein level, erythrocyte sedimentation rate or the white
blood cell count of the synovial fluid.
Marker expression in cultured cells
The direct ex vivo cell characterization involves the
comparison with standard plastic-adherent, cultured
cells. Therefore, cultured cells from five control
patients and five RA patients were also tested for their
surface marker profile, largely with the same antibodies
as those used in the study of the digests. Cell popula-
tion doubling was linear over time between passage
one and six [see Additional file 1]. The cells showed no
expression of CD45, CD20/CD79a, or HLA-DR, but
were positive for CD73, CD90, and CD105 in passage
three and six (Table 4). The plots are shown in Addi-
tional file 2. Data were variable for the marker CD34.
Most cultures showed expression of this marker which
did not decrease during passaging. This result was
tested and confirmed by PCR or quantitative PCR in a
series of 10 other cell cultures (data not shown).
Expression of CD34 was lower in RA cultures than in
control cultures in parallel with the fresh digests, but
this was not statistically significant. Low levels of CD14
were detected in most cultures but tended to decrease
during passaging.
Figure 4 Influence of the isolation procedure on the detection of stromal markers. (a) Dot plot showing CD34- allophycocyanin (APC) and
isotype staining of viable CD45-positive CD34-enriched cord blood mononuclear cells (CB-MNCs) before and after exposure to the digestion
method. (b) Plots showing (top panel) human leucocyte antigen (HLA)-DR- phycoerythrin (PE) staining and (lower panel) forward scatter (FSC)/
side scatter (SSC) of viable, CD45-positive peripheral blood mononuclear cells (PBMCs) before and after exposure to the digestion method. (c)
Dot plots showing CD73-PE, CD105- fluoro-isothiocyanate (FITC) and isotype stainings of cultured passage five synovium-derived mesenchymal
stem cells. (d) Plots showing CD146-PE and isotype staining in viable (negative for 7-aminoactinomycin (7-AAD) in peridinin chlorophyll protein
channel) human osteosarcoma cells before and after exposure to the digestion method.
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Page 8 of 14Detection of CD271 as a specific marker for a stromal
subpopulation in the synovium and in expanded cells
CD271 has been associated with bone marrow-derived
mesenchymal progenitor cells but does not appear to be
present on expanded mesenchymal progenitor cells from
the synovium [14,16,17,25]. We therefore used this mole-
cule as an example to see whether CD271-positive cells
are present in the synovium. In a set of eight patients,
staining for CD34 was combined with CD271. The plots
are illustrated in Figure 7a. CD271 was expressed in most
of the samples (Figure 7b), with a median value of 4.7%
of the stromal compartment, and 3.1% of the stromal
cells were both CD271 and CD34 positive. In contrast,
expression in synovium-derived fibroblastic cells cultured
for one month was tested in three patients of whom
digest data were also available. A certain expression of
CD271 was maintained but cells positive for both CD271
and CD34 were not longer detected (Table 5).
Discussion
This study used flow cytometry to provide a novel
method for the quantification and characterization of
human synovium cell populations and showed that stro-
mal and non-stromal populations could be detected and
quantified. However, enzymatic synovial disaggregation
may be associated with changes in cell surface marker
expression, which needs to be considered when using
this approach. Given the robust nature of cytometry and
the ability to simultaneously evaluate multiple cell popu-
lations, this method has considerable potential for the
evaluation of synovial tissue.
Fresh tissue digests with good quality isolated cells
open the way to many downstream research applications
in synovial biology such as cell sorting [11], magnetic
separation, extraction of RNA or proteins, in vivo trans-
fer models and the prospective purification of putative
stem cell populations. The isolation procedure described
Figure 5 Expression level of CD45 in control samples versus arthritis samples in percentage of viable cells. Boxes = median, 25
th and
75
th percentiles. Whiskers = minimum and maximum values. *P < 0.05.
Table 3 Quantification of surface marker expression in
synovial digests
RA (n = 7) SpA (n = 12)
median (%) quartiles median (%) quartiles
CD45-positive CD3 72.7 57.9-76.7 66.6 58.6-79.6
CD14 14 7.8-22.3 12.9 6.9-16.6
CD20 4.2 1.9-6.8 4.1 2.1-6.3
CD45-negative CD34 34.1 26.1-45.2 53.8 44.4-61.9
CD90 82.1 80.1-95.3 84.9 71.8-90
Numbers indicate percentage of positive cells counted within each group of
CD45-positive or CD45-negative cells.
RA = rheumatoid arthritis; SpA = spondyloarthritis.
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Page 9 of 14here has a number of advantages. Its short timeline may
limit changes in the activation status of some cells. Also,
quality of the tissue digest can be checked by simple
microscopic cell counting with dye viability exclusion,
an assessment which was sufficient to discriminate
between our two different biopsy types. The higher cell
yield found in arthritis versus control synovium is in
line with the known features of hypertrophy and
immune cell infiltration. The higher viability using
arthritis samples cannot be explained by differences in
enzyme concentration because this was the same for
both types of samples. The mechanical disruption step
could have less impact in the case of the more loose
inflamed arthritis tissue, and as such provoke less cell
death as in the non-inflamed tissue.
However, some concerns remain and are relevant for
the cell isolation process. First, the fact that this isolation
procedure is short does not infer that cell survival or sig-
naling activity would be left unchanged. Nevertheless, far
less artifacts are expected than is the case after cell cul-
ture. The influence of the procedure can be tested sepa-
rately for each marker as we illustrated. Second,
reproducibility of digest analysis between centers can
play an important role. It is clear that for optimal results
and complete reproducibility between centers, which is
needed in clinical trials, procedures should be agreed
upon at start and standardized across centers.
Procedures for cell isolation from tumors [26], gut
mucosa [27], liver [28], and cartilage [29] were reported
to affect the final flow cytometry readout. We detected
influences on macrophage and B-cell marker expression
relying on mimicking experiments with PBMC suspen-
sions. The relative expression of macrophage markers
and B-cell markers were decreased by exposure to the
enzyme cocktail or to the rotation process, respectively.
Neither expression was restored after two hours. CD14
function has been described to be sensitive to enzymatic
Figure 6 Semi-quantitative assessment of vascularization in synovial tissue by immunohistochemistry. Magnification 100×. (a to c) von
Willebrand Factor staining. (a) Positive endothelial cells are detected. (b) Isotype control. (c) Positive (sub)endothelial cells and fibroblasts are
detected. (d to f) CD34 staining. (e) Isotype control. (c and f) Scores in different patient groups.
Table 4 Surface marker phenotype of cultured synovium-
derived cells
Control (n = 5) RA (n = 5)
Passage P3 P6 P3 P6
Marker
CD45 0000
CD14 9 (4-35) 10 (4-11) 22 (19-27) 17 (13-18)
CD34 30 (24-72) 60 (57-70) 25 (12-30) 32 (9-41)
CD20/CD79a 0000
HLA-DR 0000
CD73 100 100 100 100
CD90 99 99 99 100
CD105 98 99 98 97
Numbers indicate percentage of positive cells calculated as medians (first and
third quartiles between brackets).
RA = rheumatoid arthritis.
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Page 10 of 14Figure 7 Detection and quantification of CD271 and CD34 in digests and cultured cells. (a) Plots of two representative samples. The
CD45-negative fraction is gated in G1. Within this fraction, a portion of cells is positive for CD271 or CD34. Double positive cells are sometimes
well clustered (lower plot). To be uniform, the quantification is performed using quadrant analysis. (b) Data points representing the expression
levels in percentage positivity on the cell surface detected in the fresh digests. (c) Plots of cultured cells after staining. Cells are gated according
to scatter properties (G1), viability (G2) and the signal for the markers is compared with the isotype controls. No double positive cells are
recognized here. 7-AAD = 7-aminoactinomycin; APC = allophycocyanin; FITC = fluoro-isothiocyanate; FSC = forward scatter; PE = phycoerythrin;
SSC = side scatter.
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Page 11 of 14cleavage [30] and receptor shedding. In our case, how-
ever, selective cell death seems to be the major cause
because the population diminished equally on FSC/SSC
plots. Also, the parallel decrease of two phenotype mar-
kers on each cell type suggests cell death. On the other
hand, artefacts may be overemphasized in the mimick-
ing experiments because the normal substrates for the
digesting enzymes are not present in these conditions.
Importantly, the expression of markers used for the
stromal compartment was not decreased by the diges-
tion. This makes the method more valid for the quanti-
fication of stromal subpopulations than infiltrating
subpopulations. If the method is used to study certain
hematopoietic subsets, further study of the conditions is
necessary.
In the case of CD163 and CD20 expression, we would
have expected differences between RA and SpA patients
considering previous immunohistochemical observations
[31,32], which was not confirmed. In the stromal fraction,
we found a higher proportion of CD34-positive cells in
samples from control patients than from arthritis
patients. So, in non-inflammatory synovium, more
CD34-positive cells are recovered in relation to the other
stromal populations than in the inflammatory synovium,
which contains a bulk of hypertrophic synoviocytes in
the villi. Also, a trend towards a higher proportion of
CD34-positive cells was seen in SpA samples compared
with RA samples. The latter is in line with macroscopic
and microscopic observations of higher synovial vascular-
ity in these patients. As CD34 is not specific for blood
vessels in synovium [33] and could indicate other stromal
cells, we performed immunohistochemical assessment
combining CD34 and vWF. This confirmed the trend
towards higher vascularity in the SpA group.
The surface marker profile of directly isolated cell
populations was compared with that of plastic-adher-
ence selected cultured synovium-derived cells. We
expected the latter to have a conventional mesenchymal
stem cell profile. Unexpectedly, the expression of CD34
was present in the majority of cultures, albeit that the
signal was not as strong as for the markers CD73,
CD105, and CD90. The control samples show slightly
more CD34-expression than the RA cultures. The CD34
positivity reflects the expression on fibroblasts and not
the survival of endothelial cells or endothelial progenitor
cells in the cultures [33]. True endothelial cells are rare
in digests and unlikely to be maintained in large quanti-
ties in culture, in conditions not supporting their
growth. Instead, CD34 has been a previously unnoticed
signal in routinely cultured synovial cells through its
weakness on a high fluorescence background. In con-
trast to frozen digests, in flow cytometry of cultured
cells, this background excludes the use of multicolor
staining in order to avoid severe compensation pro-
blems, at least when using advanced passage numbers.
The baseline fluorescence of fluorescence-minus-one
and isotype controls was accepted, because a lowering
of the photomultiplier tube voltage settings would have
decreased the signal-to-noise ratio in the detectors
under the acceptable range. As sensitivity was as such
preserved, the weaker signal was still detectable. The
results were reproduced with two different antibody
clones and three different fluorochromes. However, in
bone-marrow-derived cultured cells, the CD34-signal
was absent, as also described before [34].
To challenge our method, we tested the presence of
CD271-positive cells in the synovium. This marker
appears to be absent from expanded synovial progenitor
cells [25] but is present on bone marrow-derived pro-
genitor cells and hence could be an in vivo marker of
mesenchymal stem cells [35]. Our data indicate that a
specific subpopulation of CD271-positive cells is present
in inflamed synovium but that these cells are not at all
or barely found in expanded cells populations from the
same patients. This confirms the potential value of
direct analysis to obtain direct information about stro-
mal cell populations that could play a role in arthritis.
In general, the technical hurdles for flow cytometry in
fresh digests of synovium are not larger than those in
cultured synovial cells. Cell culture will be useful to
further study functioning of the cells. However, it will
be necessary to perform cytometry of functionally
important molecules in the digests. It adds to the tech-
nique of immunohistochemistry that cells still can be
stimulated, sorted, or cultured and it is useful in parti-
cular for the stromal subpopulations.
Conclusions
This study reports on the use of enzymatic and cyto-
metric techniques for the characterization of synovial
cell populations. The major synovial tissue composition
can be quantified and classical stromal markers remain
unaffected by the digesting procedure. Further refine-
ments are needed for optimization of cell viability and
defining marker combinations specific for mesenchymal
subpopulations. These findings will help open up the
way for direct and functional studies of synovial cell
populations ex vivo in humans.
Table 5 Comparing marker expression in the digests and
cultures from the same samples
Digested Cultured
CD271 CD34 double CD271 CD34 double
Patient 1 0.2 11 0 11 1 0
Patient 2 6 40 3 10 12 0
Patient 3 16 41 13 4 0.7 0
Numbers indicate percentage of positive cells counted within the CD45-
negative gating.
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Page 12 of 14Additional file 1: PDF file containing growth curves of cell cultures
derived from (a) control and (b) inflamed synovium starting from
passage one to six. ORT = cells derived from control samples; REU = cells
derived from RA patients with active knee arthritis. Population doublings
during each passage were calculated as the logarithm to two of the fold
increase of cells (being harvested cells divided by seeded cells).
Click here for file
[http://www.biomedcentral.com/content/supplementary/ar2916-S1.pdf]
Additional file 2: PDF file containing plots showing the surface marker
profile of cultured synovium-derived cells: representative sample. (a) Dot
plots depicts the marker of interest in x-axis with 7-aminoactinomycin (7-
AAD) staining in y-axis. (b) Dot plots depicting the controls used. The
upper row shows the used isotype controls, with not much aspecific
binding. The lower row shows cells only stained with 7-AAD
(’fluorescence-minus-one’ control).
Click here for file
[http://www.biomedcentral.com/content/supplementary/ar2916-S2.pdf]
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